Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • STX vs MRNA✓SelectedUSD · MRNASTX vs MRNA performance historyLatest closeAs of-12.35%11/20
Stock and ETF performance explorer

STX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+91.1%
MRNA return
+697.5%
Excess return
-606.4%
Maximum drawdown
-58.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-12.3%-2.2%-10.2%-12.4%
7D-13.5%-12.7%-0.8%-13.6%
30D-34.4%-20.7%-13.8%-34.5%
3M-46.2%+46.3%-92.5%-45.5%
6M-39.1%+305.2%-344.3%-40.5%
YTD+66.5%+561.2%-494.7%+39.5%
1Y+91.1%+772.1%-680.9%+45.6%
All+91.1%+697.5%-606.4%+45.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling